Proposed Bill for Medicaid Coverage of Certain Fertility Drugs

Proposed Bill for Medicaid Coverage of Certain Fertility Drugs - Healthcare Law Update - May 2025 - Brach Eichler
BACK TO INSIGHTS     Articles

5/1/2025

Senate Bill 4294, introduced in the New Jersey Senate on March 24, 2025, would require Medicaid to cover ovulation enhancing drugs and the medical services related to administering such drugs for certain beneficiaries who are experiencing infertility. The scope of the Bill would apply to medical services related to prescribing and monitoring the use of such drugs for individuals 21 through 44 years of age if there is federal financial participation available. Medical services covered under the bill would be limited to office visits, hysterosalpingograms, pelvic ultrasounds, and blood testing.

Click Here to read the entire May 2025 Healthcare Law Update now!

For more information, contact:
John D. Fanburg, Chair | 973.403.3107 | jfanburg@bracheichler.com
Edward Hilzenrath | 973.403.3114 | ehilzenrath@bracheichler.com
Rebecca T. Falk | 973.364.8393 | rfalk@bracheichler.com

*This is intended to provide general information, not legal advice. Please contact the authors if you need specific advice.

Related Practices:   Healthcare Law

Related Industry:   Healthcare